fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Strides Pharma Science Ltd

Strides Pharma Science Ltd

Updated on February 19, 2020

Stock/Share Code - STAR

Strides Pharma Science is engaged in develops and manufactures a wide range of IP-led niche pharmaceutical products.

Below is the details of STAR Strides Pharma Science Ltd

Market Cap₹3,471 Cr.
Current Price ₹371.25 as on 10 Dec 19
52 Week High / Low Price₹551.4 / ₹288
Face Value₹10
Stock P/E18.45
Book Value₹353.15
Dividend Yield0.77 %
ROCE4.25 %
ROE3.53 %
Sales Growth (3yrs)-10.75 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Stock is trading at 1.10 times its book value Promoter's stake has increased Company has been maintaining a healthy dividend payout of 21.14%
Cons: The company has delivered a poor growth of 7.64% over past five years. Promoter holding is low: 31.28% Tax rate seems low Company has a low return on equity of 11.94% for last 3 years. Contingent liabilities of Rs.5724.24 Cr. Promoters have pledged 51.29% of their holding Earnings include an other income of Rs.130.30 Cr.

Strides Pharma Science Ltd Price Chart

Strides Pharma Science Ltd Price Chart

Strides Pharma Science Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹170.05 24.93 ₹107,934.08 Cr. 0.61 ₹1,064.09 Cr. 57.62 17.09 8123.35 11.19
2. Dr Reddy's Labs ₹2,897.5 17.68 ₹48,412.38 Cr. 0.69 ₹1,106.8 Cr. 113.54 26.07 4812.80 12.42
3. Cipla ₹453.05 22.78 ₹37,626.53 Cr. 0.64 ₹474.5 Cr. 25.85 9.57 4395.78 10.94
4. Piramal Enterp. ₹1,611.6 17.30 ₹36,008.74 Cr. 1.43 ₹554.69 Cr. 17.26 14.61 3603.56 9.42
5. Biocon ₹289.65 43.30 ₹33,798 Cr. 0.18 ₹215.7 Cr. -24.60 19.02 1572.20 13.39
6. Torrent Pharma. ₹13.65 37.89 ₹32,128.11 Cr. 0.90 ₹244 Cr. 36.31 5.86 2005.00 12.66
7. Aurobindo Pharma ₹432.55 9.99 ₹26,361.38 Cr. 0.56 ₹639.86 Cr. 2.69 17.87 5600.47 18.45
8. Strides Pharma 18.45 ₹3,470.62 Cr. 0.77 ₹47 Cr. 428.90 25.70 425.41 4.25

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Strides Pharma Science Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019
Sales370312366362353389350338415435443425
YOY Sales Growth %-26.96%-56.59%-27.52%-28.89%-4.55%24.88%-4.44%-6.39%17.46%11.71%26.52%25.7%
Expenses374276369350292284322342382357395362
Material Cost %58.61%45.67%64.01%60.56%49.26%39.61%61.05%59.98%57.92%51.12%59.18%52.88%
Employee Cost %16.96%19.15%14.82%16.97%15.42%14.07%14.97%20.4%12.77%11.25%11.65%13.18%
Operating Profit-436-3126110528-333784864
OPM %-1%11%-1%3%17%27%8%-1%8%18%11%15%
Other Income3571633573710162020552332
Interest181826232211111115161715
Depreciation172118192021202120222323
Profit before tax-4671659178312-1618953058
Tax %-457%-12%44%-141%-16%3%12%8%14%-4%19%19%
Net Profit-257591310576111-1415992547
EPS in Rs-2.748.411.001.4011.7884.971.18-1.601.7111.042.765.25
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales4135937685047507121,0649292,1621,3821,4701,5371,717
Sales Growth %-9.28%43.66%29.54%-34.41%48.74%-5.02%49.42%-12.64%132.65%-36.1%6.35%4.62%%
Expenses4426646605066016169358161,9341,2691,2741,4021,495
Material Cost %56.31%57.67%56.66%58.27%57.59%54.57%58.45%55.54%56.62%53.15%53.16%57.16%%
Manufacturing Cost %10.52%8.86%7.13%4.64%3.44%3.45%3.94%4.97%6.41%8.94%8.67%7.53%%
Employee Cost %11.53%10.11%10.39%9.37%8.4%9.96%10.47%12.93%12.68%16.53%15.28%14.52%%
Other Cost %28.6%35.35%11.69%28.1%10.71%18.59%15.01%14.33%13.73%13.23%9.6%12.01%%
Operating Profit-29-71109-214996129114228112195135222
OPM %-7%-12%14%-0%20%13%12%12%11%8%13%9%13%
Other Income-251609321076554,635639122169864111130
Interest45656210481711053410372825463
Depreciation191923151819474910370788388
Profit before tax-118411789126604,612669145139899109201
Tax %2%-38%9%17%7%7%24%20%10%22%1%-1%
Net Profit-115610674118563,513532130109892110186
EPS in Rs0.001.5323.4212.4919.879.20471.5389.3114.4312.1499.6212.3220.76
Dividend Payout %-0%0%6%12%10%21%86%121%34%37%2%24%

Compounded Sales Growth

  • 10 Years:: 9.99%
  • 5 Years:: 7.64%
  • 3 Years:: -10.75%
  • TTM:: 20.06%

Compounded Profit Growth

  • 10 Years:: 8.21%
  • 5 Years:: 1.61%
  • 3 Years:: 6.56%
  • TTM:: -78.71%

Return on Equity

  • 10 Years:: 5.97%
  • 5 Years:: -15.67%
  • 3 Years:: -28.78%
  • 1 Year:: -20.20%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Sep 2019
Share Capital84898958585960608989909090
Preference Capital49.1649.1649.16000000000
Equity Capital3540.0540.2257.7558.3858.859.5759.6289.3589.4289.589.5589.55
Reserves1602908211,3461,3011,3131,5711,4153,0683,1433,0723,1673,073
Borrowings1,0631,0971,2321,2438946344734051,5451,608606811801
Other Liabilities3383264683971,036303344286665730563639574
Trade Payables168.71164.96212.49188.28209.6181.1144.79159.01505.06476.7391.1511.3452.23
Total Liabilities1,5961,7542,5613,0443,2902,3092,4472,1655,3675,5714,3314,7074,538
Fixed Assets1661613273123243063813949841,194564574655
Gross Block254.18267.47428.53445.11494.09509.81621.34685.951080.891417.73754.22842.5
Accumulated Depreciation88.63106.21113.42133.56170.18203.55240.49291.4597.31223.9190.26268.89
CWIP501451138730373918015814412273
Investments8369401,5188657871,2951,0479682,4472,5201,7772,1492,032
Other Assets5445077051,8302,1726779827631,7561,6991,8471,8621,778
Inventories72.2186.9795.5129.31130.32104.35136.8155.4379.23409.53269.63473.34424.48
Trade receivables180.22286.32207.53159.73264.29193.1273.29256.01692.4540.69449.37582.56688.74
Cash Equivalents125.5916.3831.3881.0381.4629.33174.9674.394.3494.9279.79180.81108.47
Loans n Advances166.25117.63370.421459.941112.42258.39247.66183.14428.3363.54489.01397.33156.88
Other Assets etc0000583.5292.26149.7594.51161.83290.45559.1228.44399.17
Total Assets1,5961,7542,5613,0443,2902,3092,4472,1655,3675,5714,3314,7074,538

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity489538489811-3207834126640
Profit from operations35.1886.04131.5471.68157.9379.53206.16198.02301.37317.39245.03198.52
Working Capital Changes16.2110.2-83.38-6.34-33.85-34.08-143.5658.46-168.93131.16-161.75-121.04
Taxes paid-3.19-1.43-9.85-17.2-22.38-34.31-65.95-49.09-49.36-36.81-17.68-37.52
Cash from Investing Activity-639-112-143-347-49013,999305-1,062-883433-166
Fixed Assets Purchased-65.74-111.64-84.46-40.01-23.29-43.04-224.96-69.04-271.17-353.41-197.64-86.13
Fixed Assets Sold0.253.080.310.640.520.633.230.382.78112.155.294.07
Investments purchased0000-10.20-40-361.5-367.73-528.19-192.750
Investments sold5.52123.170015.370.043528.41392.1470.54413.031063.07234.54
Cash from Financing Activity698-92118347-93-962-3,498-8021,571-67-707123
Proceeds from Shares0015.89503.177.258.8725.951.611164.253.393.631.4
Proceeds from Borrowings177.430241.5410.72330.510.720.490822.21217.46297.42191.53
Repayment of Borrowings-23.33-49.43-23.11-221.91-358.77-276.57-184.96-76.55-279.59-131.72-843.73-0.94
Interest Paid-37.73-43-45.27-81.29-61.75-65.66-71.22-20.95-77.35-113.14-119.81-50.78
Dividends Paid-6.9100-7.58-10.07-11.74-2990.09-655.22-24.61-35.75-44.29-17.95
Net Cash Flow108-11014482-50497-290592-538-208-3

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Dec 2007Dec 2008Dec 2009Dec 2010Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %-1%8%6%6%6%9%11%9%6%5%24%4%
Debtor Days159176991161299994101117143112138
Inventory Turnover6.077.458.424.485.776.078.826.368.093.504.334.14

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Strides Pharma Science Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.